Group
CD137 agonist mAb
The data below refer to patients treated with CD137 agonist mAb as the sole drug class,
excluding any concurrent use of drugs from other groups.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.
Urelumab
No data